Business Description
Qinghai Spring Medicinal Resources Technology Co Ltd
NAICS : 211111
SIC : 1231
ISIN : CNE0000017W0
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.93 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 20.41 | |||||
Beneish M-Score | -3.81 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.5 | |||||
3-Year EBITDA Growth Rate | -56.9 | |||||
3-Year EPS without NRI Growth Rate | 9.1 | |||||
3-Year Book Growth Rate | -15.1 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.78 | |||||
9-Day RSI | 48.17 | |||||
14-Day RSI | 50.81 | |||||
6-1 Month Momentum % | 11.07 | |||||
12-1 Month Momentum % | -64.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.73 | |||||
Quick Ratio | 7.06 | |||||
Cash Ratio | 2.51 | |||||
Days Inventory | 648.13 | |||||
Days Sales Outstanding | 65.11 | |||||
Days Payable | 23.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.11 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.1 | |||||
Operating Margin % | -49.24 | |||||
Net Margin % | -114.65 | |||||
FCF Margin % | 11.25 | |||||
ROE % | -22.86 | |||||
ROA % | -21.71 | |||||
ROIC % | -11.15 | |||||
ROC (Joel Greenblatt) % | -36.82 | |||||
ROCE % | -22 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.59 | |||||
PB Ratio | 1.58 | |||||
Price-to-Tangible-Book | 1.71 | |||||
Price-to-Free-Cash-Flow | 57.05 | |||||
Price-to-Operating-Cash-Flow | 47.55 | |||||
EV-to-EBIT | -5.93 | |||||
EV-to-EBITDA | -5.93 | |||||
EV-to-Revenue | 6.61 | |||||
EV-to-FCF | 66.82 | |||||
Price-to-Median-PS-Value | 0.61 | |||||
Price-to-Net-Current-Asset-Value | 3.27 | |||||
Price-to-Net-Cash | 21.93 | |||||
Earnings Yield (Greenblatt) % | -16.86 | |||||
FCF Yield % | 1.56 | |||||
Forward Rate of Return (Yacktman) % | -38.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Qinghai Spring Medicinal Resources Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 251.198 | ||
EPS (TTM) (Â¥) | -0.495 | ||
Beta | -0.1 | ||
Volatility % | 89.16 | ||
14-Day RSI | 50.81 | ||
14-Day ATR (Â¥) | 0.147112 | ||
20-Day SMA (Â¥) | 3.1375 | ||
12-1 Month Momentum % | -64.16 | ||
52-Week Range (Â¥) | 1.84 - 8.43 | ||
Shares Outstanding (Mil) | 587.06 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Qinghai Spring Medicinal Resources Technology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Qinghai Spring Medicinal Resources Technology Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Qinghai Spring Medicinal Resources Technology Co Ltd Frequently Asked Questions
What is Qinghai Spring Medicinal Resources Technology Co Ltd(SHSE:600381)'s stock price today?
When is next earnings date of Qinghai Spring Medicinal Resources Technology Co Ltd(SHSE:600381)?
Does Qinghai Spring Medicinal Resources Technology Co Ltd(SHSE:600381) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |